相关实验视频
Updated: Jun 4, 2025

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
8.0K
在儿科人口中,在蜂毒免疫疗法期间出现过敏反应
Jessica W S Wong1, Ashling Courtney1, Tess O'Gorman1
1Department of Immunology, Perth Children's Hospital, Nedlands, Western Australia, Australia.
Journal of paediatrics and child health
|December 23, 2024
概括
在蜂毒免疫疗法 (BVIT) 期间经历过敏反应的儿童继续治疗的风险较低. 然而,在维护BVIT期间出现过敏反应的人不太可能耐受持续的免疫治疗.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 儿科过敏 儿科过敏
- 免疫治疗是一种免疫疗法.
背景情况:
- 蜜蜂毒液免疫疗法 (BVIT) 是一种常见的治疗方法,用于对白虫毒液过敏.
- 过敏反应是BVIT期间的潜在不良事件,需要谨慎管理.
- 了解过敏反应后的结果对于优化BVIT协议至关重要.
研究的目的:
- 在儿科BVIT期间审查过敏反应发作.
- 分析过敏反应后的剂量计划修改和结果.
- 评估在患有过敏反应的儿童中BVIT的安全性和耐受性.
主要方法:
- 在西澳大利亚从2012年至2021年接受BVIT的儿童的回顾性研究.
- 收集的数据包括患者人口统计,过敏反应时的剂量和BVIT疗程修改.
- 评估的结果包括BVIT的延续,修改或终止以及随后的耐受性.
主要成果:
- 在624名儿童中,1.9%的儿童没有完成BVIT,主要是由于不遵守.
- 5.2% (33名儿童) 经历了36次过敏反应,主要发生在第一天 (56%).
- 在积累阶段经历过敏反应的儿童在当天继续 (83.3%) 或重新开始 (64.7%) 时有良好的耐受性;50%的维护阶段过敏反应患者可以容忍持续的免疫治疗.
结论:
- 积累阶段过敏反应的儿童通常可以安全地继续或重新启动BVIT.
- 在BVIT的维持阶段出现过敏反应表明复发的风险较高,持续治疗的耐受性较低.
- 这些发现为儿童过敏反应事件后BVIT管理的临床决策提供了信息.
相关概念视频
Allergic Reactions
27.2K
Overview
27.2K
Allergic Drug Reactions
810
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
810
Hypersensitivities
504
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
504
Cross-reactivity
31.0K
Overview
31.0K
Adrenergic Agonists: Therapeutic Uses
725
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
725
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236

